Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.895 USD | +1.48% | -6.21% | -3.44% |
01/06 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
13/05 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 2.18B | |
-42.06% | 7.92B | |
+8.69% | 3.51B | |
-21.69% | 1.97B | |
-26.97% | 1.58B | |
+20.92% | 792M | |
-10.48% | 690M | |
-26.53% | 532M | |
-1.29% | 303M | |
-15.70% | 160M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics, Inc. Appoints Igor Bilinsky as Chief Operating Officer